Concomitant Radiochemotherapy of Cervical Cancer : IIIIIs It Justified to Reduce the Dosage of Cisplatin?

Strahlentherapie und Onkologie

Volumn 185, Issue 9, 2009, Pages 582-587

  Patyánik, Mihály ^a   Nemeskéri, Csaba ^a   Póti, Zsuzsa ^a   Sinkó, Dániel ^a   Pesznyák, Csilla ^a   Király, Réka ^a   Kois, Róbert ^b   Mayer, Árpád ^a  

^a UZSOKI HOSPITAL   (Hungary)

^b St Stephen and St Leslie United Hospital of the Municipal Government   (Hungary)

Author keywords

Cervical cancer; Radiochemotherapy; Toxicity

Indexed keywords

CISPLATIN;

ADULT; AGED; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER RADIOTHERAPY; CANCER STAGING; CONTROLLED STUDY; FEMALE; GASTROINTESTINAL TOXICITY; HUMAN; LEUKOPENIA; MAJOR CLINICAL STUDY; PELVIS; REVIEW; TREATMENT RESPONSE; UTERINE CERVIX CANCER;

ADULT; AGED; ANTINEOPLASTIC AGENTS; CISPLATIN; COMBINED MODALITY THERAPY; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; NEOPLASM STAGING; UTERINE CERVICAL NEOPLASMS;

EID: 70349210560     PISSN: 01797158     EISSN: 1439099X     Source Type: Journal    
DOI: 10.1007/s00066-009-1974-z     Document Type: Review

References (32)

1. K.K. Ang 2004 Concurrent radiation chemotherapy for locally advanced head and neck carcinoma: are we addressing burning subjects J Clin Oncol 22 4607 59 10.1200/JCO.2004.07.962 (Pubitemid 41185072)
2. Arriagada R, Goldstraw P, Le Chevalier T. Management of non-small-cell lung cancer. In: Souhami RL, Tannock I, Hohenburger P, et al., eds. Oxford textbook of oncology, 2nd edn. Oxford-New York: Oxford University Press, 2002:2089-110.
3. N.S. Bese J. Hendry B. Jeremic 2007 Effect of prolongation of overall treatment time due to unplanned interruption during radiotherapy of different tumour sites and practical methods for compensation Int J Radiat Oncol Biol Phys 68 654 61 17467926
4. K. Dellas M. Bache S.U. Pigorsch 2008 Prognostic impact of HIF-1 alfa expression in patients with definitive radiotherapy for cervical cancer Strahlenther Onkol 184 169 74 18330514 10.1007/s00066-008-1764-z
5. W. Dörr S. Köst K. Keinert 2006 Early intestinal changes following abdominal radiotherapy. Comparison of endpoints Strahlenther Onkol 182 1 8 16404514 10.1007/s00066-006-1471-6 (Pubitemid 43069829)
6. Eifel PJ, Rose PG. Chemotherapy and radiation therapy for cervical cancer. In: ASCO 2000 educational book. Alexandria: ASCO, 2000:199-206.
7. J. Füller D. Guderian C. Köhler 2008 Lymph edema of the lower extremities after lymphadenectomy and radiotherapy for cervical cancer Strahlenther Onkol 184 206 11 18398585 10.1007/s00066-008-1728-3
8. M.M. Hreshchyshyn B.S. Aron R.C. Boronow 1979 Hydroxyurea or placebo combined with radiation to treat stages IIB and IV cervical cancer confined to the pelvis Int J Radiat Oncol Biol Phys 5 317 72 110744 1:STN:280: DyaE1M3hsF2jtw%3D%3D
9. H. Ikushima K. Osaki S. Furutan 2006 Chemoradiation therapy for cervical cancer: toxicity of concurrent weekly cisplatin Radiat Med 24 115 21 16715672 10.1007/BF02493277 1:CAS:528:DC%2BD28Xks1Cgs74%3D
10. H.M. Keys B.N. Bundy F.B. Stehman 1999 Cisplatin, radiation, and adjuvant hysterectomy for bulky stage IB cervical carcinoma N Engl J Med 340 1154 61 10202166 10.1056/NEJM199904153401503 1:CAS:528:DyaK1MXislKgtLg%3D (Pubitemid 29177874)
11. S. Marnitz C. Köhler J. Füller 2006 Uterus necrosis after radiochemotherapy in two patients with advanced cervical cancer Strahlenther Onkol 182 45 51 16404520 10.1007/s00066-006-1455-6 (Pubitemid 43069835)
12. S. Marnitz C. Köhler C. Roth 2007 Stage-adjusted chemoradiation in cervical cancer after transperitoneal laparoscopic staging Strahlenther Onkol 183 473 8 17762920 10.1007/s00066-007-1675-4 (Pubitemid 47347927)
13. S. Marnitz C. Köhler A. Schneider 2006 Interindividual variability of lymph drainages in patients with cervical cancer. Implication on irradiation planning Strahlenther Onkol 185 80 5 10.1007/s00066-006-1470-7 (Pubitemid 43177192)
14. Mayer 1998 Brachyterápia tegnap és ma Magy Onkol 42 5 8
15. Mayer 1999 Radioterápia az ezredfordulón Orv Hetil 140 1875 80 10502969 1:STN:280:DyaK1Mvjt1GrtQ%3D%3D
16. Mayer C. Nemeskeri C. Petnehazi 2004 Primary radiotherapy of stage IIA/B-IIIB cervical carcinoma. A comparison of continuous versus sequential regimens Strahlenther Onkol 180 209 15 15057431 10.1007/s00066-004-1122-8 (Pubitemid 38461545)
17. M. Morris P.J. Eifel J. Lu 1999 Pelvic radiation with concurrent chemotherapy compared with pelvic and paraaortic radiation for high-risk cervical cancer N Engl J Med 340 1137 43 10202164 10.1056/NEJM199904153401501 1:STN:280:DyaK1M3gtVOntg%3D%3D (Pubitemid 29177872)
18. V. Nagy O. Coza C. Ordeanu 2008 Radiotherapy versus concurrent 5-day cisplatin and radiotherapy in locally advanced cervical carcinoma Strahlenther Onkol 185 177 83 10.1007/s00066-009-1893-z
19. National Cancer Institute. Clinical announcement. Bethesda: United States Department of Health and Human Services, Public Health Service, February 1999.
20. National Cancer Institute Common Terminology Criteria for Adverse Events v 3.0 2003 Cancer therapy evaluation program NCI Bethesda, MD, USA National Cancer Institute Common Terminology Criteria for Adverse Events v 3.0 (CTCAE). Cancer therapy evaluation program. Bethesda, MD, USA: NCI, 2003 http://ctep.cancer.gov
21. K. Ohara Y.O. Tanaka H. Tsunoda 2005 Preliminary estimation of treatment effect on uterine cervical squamous cell carcinoma in terms of tumor regression rate: comparison between chemoradiotherapy and radiotherapy alone radiation Radiat Med 23 25 9 15786748
22. Perez CA, Brady LW. Late radiation morbidity scoring criteria RTOG/EORTC. In: Perez CA, Brady LW, eds. Priciples and practice of radiation oncology, 2nd edn. Philadelphia: Lippincott, 1993:53-5.
23. W.A.I. Peters P.Y. Liu R. Barrett 1999 Cisplatin, 5-fluorouracil plus radiation therapy are superior to radiation therapy as adjunctive therapy in high-risk, early-stage carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy. Report of phase III Intergroup Study Gynecol Oncol 72 443 10.1006/gyno.1998.5330
24. Z. Póti M. Patyánik C. Nemekéri 2006 Méhnyakrák radiochemoterápiája (kemoterá piás dózisredukció szükségessége) Orv Hetil 147 1315 20 16999017
25. P.G. Rose B.N. Bundy E.B. Watkins 1999 Concurrent cisplatin-based chemotherapy and radiotherapy for locally advanced cervical cancer N Engl J Med 340 1144 53 10202165 10.1056/NEJM199904153401502 1:CAS:528:DyaK1MXislKgtLs%3D (Pubitemid 29177873)
26. C. Schaake-Koning H. Bartelnink B.H. Adema 1986 Radiotherapy and cisdiammine dichloroplatinium (II) as a combined treatment modality for inoperable non-small cell lung cancer: a dose finding study Int J Radiat Oncol Biol Phys 12 379 83 3082809 1:STN:280:DyaL287mslKktQ%3D%3D
27. J.H. Shepherd 1995 Staging announcement FIGO staging of gynecologic cancers: cervical and vulva Int J Gynecol Cancer 5 319
28. L. Souhami R. Seymour T.N. Roman 1993 Weekly cisplatin plus external beam radiotherapy and high dose rate brachytherapy in patients with locally advanced carcinoma of the cervix Int J Radiat Oncol Biol Phys 27 871 8 8244817 1:STN:280:DyaK2c%2FmsVCgtg%3D%3D
29. F. Sterzing C. Grehn J. Dinkel 2007 Severe reversible toxic encephalopathy induced by cisplatin in a patient with cervical carcinoma receiving combined radiochemotherapy Strahlenther Onkol 183 487 9 17762922 10.1007/s00066-007-1732-z (Pubitemid 47347931)
30. J. van der Zee D. Gonzalez Gonzalez G.C. van Rhoon 2000 Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: a prospective, randomised, multicentre trial. Dutch Deep Hyperthermia Group Lancet 355 1119 25 10791373 10.1016/S0140-6736(00)02059-6
31. H. Varveris S. Kachris M. Mazonakis 2006 Phase I/II trial of external irradiation plus medium-dose brachytherapy given concurrently to liposomal doxorubicin and cisplatin for advanced uterine cervix carcinoma Strahlenther Onkol 182 125 34 16520906 10.1007/s00066-006-1440-0
32. C.W. Whitney W. Sause B.N. Bundy 1999 Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stages IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study J Clin Oncol 17 1339 48 10334517 1:CAS:528:DyaK1MXjsF2msrs%3D